| scholarly article | Q13442814 |
| P2093 | author name string | R. R. McKendall | |
| J. R. Baringer | |||
| T. Klassen | |||
| P2860 | cites work | Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection | Q34123889 |
| Passive immunization in experimental Herpesvirus hominis infection of newborn mice | Q34131920 | ||
| Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection | Q34136020 | ||
| Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation | Q34403156 | ||
| Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection | Q34483710 | ||
| THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING | Q36266931 | ||
| Minicultures of mammalian cells in a new plastic plate | Q37183841 | ||
| Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Efficacy of Immunization | Q39934802 | ||
| Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes | Q39953059 | ||
| Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection | Q39968639 | ||
| The natural history of recurrent herpes simplex labialis: implications for antiviral therapy | Q40074837 | ||
| A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans | Q44554983 | ||
| Herpes virus latency in spinal ganglia of mice without illness. | Q45818056 | ||
| Morphological studies of the neural spread of herpes simplex virus to the central nervous system | Q45825718 | ||
| Spread of herpes simplex virus in peripheral nerves | Q45827547 | ||
| A serologic study of herpesvirus hominis strains by microneutralization tests | Q68565695 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiology | Q7193 |
| antibody | Q79460 | ||
| immunology | Q101929 | ||
| pathogen spread | Q50156634 | ||
| P304 | page(s) | 305-311 | |
| P577 | publication date | 1979-02-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread | |
| P478 | volume | 23 |
| Q27486833 | Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing) |
| Q36432263 | Antibody responses in humans to individual proteins of herpes simplex viruses |
| Q45800301 | Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1. |
| Q45804923 | Effects of genetic resistance against Herpes simplex virus in vaginally infected mice |
| Q33981823 | Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1 |
| Q33932893 | Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine |
| Q45275287 | Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection. |
| Q45842445 | Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization |
| Q36852943 | Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine |
| Q36422499 | Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. |
| Q34529794 | Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus |
| Q33903740 | Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus. |
| Q33821358 | Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo |
| Q33906859 | Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice |
| Q45799569 | Mechanism of Antibody-Mediated Protection against Herpes Simplex Virus Infection in Athymic Nude Mice: Requirement of Fc Portion of Antibody |
| Q36918805 | Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia |
| Q27486805 | Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice |
| Q41364707 | Neurovirulence and latency in inbred mice of two HSV-1 intrastrain variants of divergent pathogenicity |
| Q33802025 | Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice |
| Q45806467 | Preparation of Stable Target Cells for Anti-Herpes Simplex Virus Cytotoxic T Lymphocytes |
| Q35540752 | Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin |
| Q48687001 | Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice |
| Q36333640 | Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 |
| Q44298487 | Protective effects of anti-glycoprotein D monoclonal antibodies in murine herpetic keratitis |
| Q45805645 | Protective effects of interferon, various anti-viral drugs and combinations of these on Herpes simplex virus infection in mice |
| Q43972241 | Protective immunization of mice with specific HSV-1 glycoproteins |
| Q37109269 | Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes |
| Q36728688 | Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells |
| Q36423892 | Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections. |
| Q33603438 | Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts |
| Q36899596 | Role of antibody in primary and recurrent herpes simplex virus infection |
| Q33980379 | Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice |
| Q45801486 | The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice |
| Q45777620 | The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice |
| Q36429254 | Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease |
| Q33836053 | Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells |
| Q34653920 | Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs |
Search more.